மூத்தவர் பெருநிறுவன அதிகாரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மூத்தவர் பெருநிறுவன அதிகாரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மூத்தவர் பெருநிறுவன அதிகாரி Today - Breaking & Trending Today

ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results


ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results
ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results
Phase 2/3 pivotal
Brighten pediatric trial of sepofarsen to begin in 2021; additional data from Phase 1/2
InSight extension study to be reported in H2 2021
QR-421a
Stellar Phase 1/2 trial for Usher syndrome and non-syndromic retinitis pigmentosa interim analysis on track for late Q1/early Q2 2021
Further pipeline progress anticipated with first clinical data in 2021 from QR-1123 program for autosomal dominant retinitis pigmentosa and QR-504a clinical study in Fuchs endothelial corneal dystrophy expected to start in H1 2021
Cash runway into 2023 ....

United States , Sarah Kiely , Naveed Shams , Exchange Commission , Foundation Fighting Blindness My Retina Tracker Program , Head Of Global Research , European Union , Ionis Pharmaceuticals , Program Updates , Fourth Quarter , Full Year , Stellar Phase , Scientific Advisory Board , Chief Scientific , Fuchs Endothelial Corneal Dystrophy , Chief Scientific Officer , Senior Corporate Officer , Global Research , Pontifax Ventures , Kreos Capital , Foundation Fighting Blindness , Retina Tracker , Statutory Annual Report , Leber Congenital Amaurosis , Usher Syndrome Type , Non Syndromic Retinitis Pigmentosa ,

Atsushi Sugita Succeeds Koichi Takagi as President & CEO of Maruho


Atsushi Sugita Succeeds Koichi Takagi as President & CEO of Maruho
USA - English
News provided by
Share this article
Share this article
OSAKA, Japan, Jan. 8, 2021 /PRNewswire/ Maruho Co., Ltd. (hereinafter Maruho ), based in Osaka, Japan, announced that its Board of Directors has named Atsushi Sugita Representative Director, President & CEO, effective December 18, 2020. Koichi Takagi has served as President & CEO since 1999 and remains as Chairman of the Board.
A native of Osaka, Japan, Sugita received his bachelor s degree in economics from Kyoto University in 1997, and went on to obtain an MBA from the Kellogg School of Management at Northwestern University in 2005. After working at Johnson & Johnson s U.S. headquarters and Janssen Japan, Sugita joined Maruho in 2012. After holding various positions at Maruho s R&D Labs, Head Office, and global subsidiaries, Sugita was elected to the Maruho Board in 2016, becoming Senior Corporate Officer in charge of ....

Koichi Takagi , Prnewswire Maruho Co Ltd , Head Office , Kellogg School Of Management At Northwestern University , Business Operations Administration , Kyoto University , Maruho Co Ltd , Business Development , Atsushi Sugita Representative Director , Kellogg School , Northwestern University , Janssen Japan , Maruho Board , Senior Corporate Officer , Global Strategy , Executive Corporate Officer , Business Operations , Executive Vice President , Maruho Co , Medical Pharmaceuticals , Health Care Amp Hospitals , Banking Amp Financial Services , Personnel Announcements , கொவீசி தாக்காகி , தலை அலுவலகம் , கெலோக் பள்ளி ஆஃப் மேலாண்மை இல் வடமேற்கு பல்கலைக்கழகம் ,